SRX Global Inc. (SRXH) Dividend Safety Gauge & 10-Year DRIP Compounder

SRXH scores 18 out of 100 with a letter grade of E, labeled "Roarable Strong Sell — Forensic Risk / Avoid." Across the five pillars: Fundamental Cash Engine scores 2/20 (ROIC -35%; FCF yield 0%); Whale 13F Flow scores 3/20 (institutional accumulation and options positioning); Insider Conviction scores 3/20 (SEC Form 4 and Congressional PTR cluster flow); Macro Regime Fit scores 8/20 (Beta 1.0; sector sensitivity); and Forensic Balance Sheet scores 2/20 (Altman Z 0.2; Piotroski F 1/9; Debt/Equity 0.5). Taken together, the weakest pillars sit in cash generation and balance-sheet forensics, which are the areas where the reported numbers are most concerning. For a prospective investor evaluating the stock today, the rating points to high fundamental and forensic risk, with the stock's $1.01 price and $20.5M market capitalization reflecting a very small equity value relative to reported losses. Investor implications are analytical only and not personalized financial advice.

SRX Global Inc. Is a NYSE-listed issuer in the Consumer Staples sector, operating in Beverages (Production/Distribution)..0B. —: specific products, customers, or revenue model details beyond the sector and industry classification.

Per the market data, gross margin is 23.4%, while operating and net margins are each -60%, and ROIC is -35%. The Altman Z-Score is 0.2 and the Piotroski F-Score is 1/9, with Debt/Equity at 0.5. Reported revenue declined from $38.6M (FY 2023) to $6.5M (FY 2025), and net income was -$45.0M in FY 2025. Per the financials, filing dates are 2025-09-30 for FY 2025 and 2024-12-31 for FY 2024.

• 🐂 Primary Bull Case: A GREEN-tagged catalyst on a balance-sheet update and share buyback could signal management action on the capital structure. With Fundamental Cash Engine at 2/20 (ROIC -35.0%, FCF yield —) and Institutional Whale Flow at 3/20, sustained execution supports upside toward the top of the $0.85 – $42.60 52-week range.
• 🐻 Primary Bear Case: A 2% negative ROIC of -35% and an Altman Z-Score of 0.2 indicate severe forensic and cash-generation weakness. Investors must weigh current valuation against -60.0% operating margins and a 1.00 macro beta if sector demand softens.

Upstream and downstream dependencies, sector correlations, and second-order bottlenecks are therefore — Investors should note that the absence of mapped links means ripple effects from suppliers, distributors, or customers cannot be assessed from the provided sources.

• Key Question #1: What drove the sharp revenue decline from $35.0M (FY 2024) to $6.5M (FY 2025), and is it structural or one-time?
• Key Question #2: The -$45.0M FY 2025 net income is far larger than the -$11.4M operating loss. What non-operating items account for the gap?
• Key Question #3: What are the terms, size, and timing of the share buyback referenced in the news feed, and how is it funded given low cash and negative FCF?